0 — Class II drug recall D-1096-2014
Terminated recall by Hospira Inc., reported 2014-03-12, distributed nationwide. Lack of Assurance of Sterility:Solution leaking through the port cover of the primary container, which was ide
| Recall number | D-1096-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2014-02-11 |
| Classified | 2014-03-03 |
| Reported by FDA | 2014-03-12 |
| Terminated | 2015-03-17 |
| Distributed | Nationwide (US) |
| Quantity | 603,768 bags |
| Reason classes | sterility, packaging |
| NDC | 00409-7983-09 |
| Lot numbers | 10/15, 34-609-FW |
Product
0.9% Sodium Chloride Injection, USP 1000 mL Flexible Container, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7983-09
Reason for recall
Lack of Assurance of Sterility:Solution leaking through the port cover of the primary container, which was identified during a retain sample visual inspection.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1096-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.